The company will not receive any of the proceeds from the sales of its common stock by the selling securityholders. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on ENSC: Ensysce leadership participates at Annual Pain Therapeutics Summit Ensysce Biosciences responds to recent shareholder inquiries Ensysce Biosciences receives Nasdaq notice Ensysce Biosciences to present at upcoming meetings Ensysce Biosciences submits Phase 3 protocol to FDA Disclaimer & DisclosureReport an Issue
